Latest

1 story

Hide weekly roundups

Monday, September 28

AstraZeneca completes Phase 1 laroprovstat/ezetimibe bioavailability study in healthy adults

Weekly roundup, 2 itemsacalabrutinib AstraZeneca

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.